Clinical trial
Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease
NCT06706947 is registered in ClinicalTrials.gov with Luo Xinxin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease
- Lead sponsor
- Luo Xinxin
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 1, 2024
- Completion date
- December 31, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease (ad)